Laddar...
Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS
The fixed-dose combination (FDC) elvitegravir/cobicistat/emtricitabine/tenofovir (EVG/c/FTC/TDF) is a once-daily, single-tablet regimen containing an integrase strand transfer inhibitor and a pharmacoenhancer (cobicistat) associated with two nucleos(t)ide reverse transcriptase inhibitors. It is appr...
Sparad:
| I publikationen: | Patient Prefer Adherence |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4556264/ https://ncbi.nlm.nih.gov/pubmed/26345643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S88490 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|